Showing results (1-10 of 89) with videos related to
Sort By:
Pageof 9
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 20, 2020
Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In VivoSarah A Richman, Liang-Chuan Wang, Edmund K Moon, et al.Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|November 27, 2012
Laboratory testing for prescription opioidsMichael C MiloneMolecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2019
Imaging CAR T Cell Trafficking with eDHFR as a PET Reporter GeneMark A Sellmyer, Sarah A Richman, Katheryn Lohith, et al.Cancer Immunology Research|November 29, 2017
High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma ModelSarah A Richman, Selene Nunez-Cruz, Babak Moghimi, et al.Journal of Visualized Experiments : Jove|January 7, 2020
Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive ImmunotherapySaba Ghassemi, Michael C MiloneMolecular Therapy. Methods & Clinical Development|March 20, 2018
The Pharmacology of T Cell TherapiesMichael C Milone, Vijay G BhojClinical Chemistry|December 30, 2018
Immunotherapy Using Chimeric Antigen Receptor-Engineered T Cells: A Novel Cellular Therapy with Important Implications for the Clinical LaboratorySuzanne R Thibodeaux, Michael C MiloneAnnual Review of Pharmacology and Toxicology|October 9, 2020
Pharmacology of Chimeric Antigen Receptor-Modified T CellsEdward Z Song, Michael C MiloneMethods in Molecular Biology (Clifton, N.J.)|November 29, 2019
Testing the Specificity of Compounds Designed to Inhibit CPT1A in T CellsRoddy S O'Connor, Michael C MilonePageof 9